Nuo Therapeutics, Inc. Business Combination, Consideration Transferred
Nuo Therapeutics, Inc. (AURX) reported Business Combination, Consideration Transferred of $31.75 million for the 12-month period ending 2013-12-31, per its 10-K filed 2014-03-31.
Discontinued › Notes › Business Combinations › Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation › Business Combination, Consideration Transferred
us-gaap:BusinessCombinationConsiderationTransferred1 · last filed 2014-03-31
- Nuo Therapeutics, Inc. business combination, consideration transferred for fiscal 2013 was $31.75M.
| Period end | Business Combination, Consideration Transferred 12 month |
|---|---|
| 2013-12-31 | $31.75M 10-K · filed 2014-03-31 |